Clinical Trials on Relapsed, Refractory Multiple Myeloma
Total 4770 results
-
Nanjing IASO Biotechnology Co., Ltd.Ruijin HospitalRecruitingPlasma Cell Leukemia | Relapsed/Refractory Multiple MyelomaChina
-
Chunrui LiNanjing IASO Biotechnology Co., LtdRecruitingPlasma Cell Leukemia | Relapsed/Refractory Multiple MyelomaChina
-
National Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Plasma Cell NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedStage III Multiple Myeloma | Unspecified Adult Solid Tumor, Protocol Specific | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Hangzhou Sumgen Biotech Co., Ltd.Active, not recruitingRelapsed or Refractory Multiple Myeloma | Hematological MalignancyChina
-
Intergroupe Francophone du MyelomeBristol-Myers Squibb; Takeda; University Hospital, Grenoble; Nantes University... and other collaboratorsTerminatedMultiple Myeloma | Genetic Condition | Relapsed and Refractory Multiple MyelomaFrance
-
Genesis Pharma S.A.Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Multiple Myeloma-Light Chain OnlyUnited States
-
Multinational Center for Quality of Life Research...Unknown
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
University of WashingtonRecruitingRefractory Multiple Myeloma | Plasma Cell Leukemia | Recurrent Multiple MyelomaUnited States
-
Cleave Biosciences, Inc.TerminatedLymphoid Hematological Malignancies | Relapsed and Refractory Multiple MyelomaCanada, United States
-
National Cancer Institute (NCI)WithdrawnAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma
-
National Cancer Institute (NCI)CompletedStage III Multiple Myeloma | Unspecified Adult Solid Tumor, Protocol Specific | Refractory Multiple Myeloma | Refractory Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States
-
GenmabRecruitingAcute Myeloid Leukemia (AML) | Diffuse Large B Cell Lymphoma (DLBCL) | Relapsed or Refractory Multiple Myeloma (RRMM)United States, Korea, Republic of, Netherlands, Denmark, Australia, New Zealand, Poland, Spain, Sweden, Czechia, Malaysia, Greece, Moldova, Republic of, Georgia, Ukraine, France, Hungary, North Macedonia, Bosnia and Herzegovina
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Active, not recruitingAcute Myeloid Leukemia | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Plasma Cell Myeloma | Aplastic Anemia | Malignant Neoplasm | Myeloproliferative Neoplasm | Indolent Non-Hodgkin Lymphoma | Acute Myeloid Leukemia in Remission | Refractory Anemia | Refractory Anemia With... and other conditionsUnited States
-
National Cancer Institute (NCI)WithdrawnHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Mayo ClinicActive, not recruitingPlasma Cell Myeloma | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Smoldering Plasma Cell MyelomaUnited States
-
University of PennsylvaniaRecruitingAcute Myeloid Leukemia (AML) | Multiple Myeloma (MM)United States
-
University Hospital, MontpellierPoitiers University HospitalUnknownPatients With Recurrent or Refractory Multiple MyelomaFrance
-
Shahid Beheshti University of Medical SciencesNot yet recruitingMultiple Myeloma, RefractoryIran, Islamic Republic of
-
Xinqiao Hospital of ChongqingSichuan Kelun-Biotech Biopharmaceutical Co., Ltd.RecruitingMultiple Myeloma, RefractoryChina
-
OncotherapeuticsKaryopharm Therapeutics IncRecruitingRefractory Multiple MyelomaUnited States
-
Karyopharm Therapeutics IncRecruiting
-
GWT-TUD GmbHActive, not recruitingRefractory Multiple MyelomaGermany
-
NanoAlvandCompletedMultiple Myeloma, Refractory
-
Mayo ClinicCompletedRefractory Multiple MyelomaUnited States
-
Mayo ClinicCompletedRefractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States
-
Roswell Park Cancer InstituteRecruitingPlasma Cell Myeloma | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Smoldering Plasma Cell MyelomaUnited States
-
Pack HealthM.D. Anderson Cancer Center; Sanofi; University of WashingtonRecruitingMultiple Myeloma | Refractory Multiple MyelomaUnited States
-
University of ChicagoNational Cancer Institute (NCI)RecruitingRefractory Multiple MyelomaUnited States
-
Hackensack Meridian HealthMerck Sharp & Dohme LLCWithdrawnMultiple Myeloma, RefractoryUnited States
-
Mayo ClinicWithdrawnMultiple Myeloma | Refractory Multiple Myeloma
-
Actinium PharmaceuticalsTerminatedRefractory Multiple MyelomaUnited States
-
Swiss Group for Clinical Cancer ResearchTerminatedRefractory Multiple MyelomaSwitzerland
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States, Italy
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedRefractory Multiple MyelomaUnited States
-
University of WashingtonAbbVieSuspendedAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Refractory Mixed Phenotype Acute Leukemia | Myeloid Neoplasm | Acute Biphenotypic Leukemia | Refractory Acute Biphenotypic Leukemia | Relapsed Acute Myeloid Leukemia | Mixed Phenotype Acute Leukemia | Relapsed Acute Biphenotypic Leukemia | Relapsed... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Mundipharma-EDO GmbHTerminatedMultiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma ProgressionSwitzerland, United States, Norway
-
National Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Plasma Cell MyelomaUnited States
-
PETHEMA FoundationRecruitingRefractory Multiple MyelomaSpain
-
Case Comprehensive Cancer CenterCompletedRefractory Multiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States
-
Attaya SuvannasankhaNational Cancer Institute (NCI)TerminatedRefractory Multiple MyelomaUnited States